Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of magnesium on cardiac biomarker proBNP in coronary artery disease
IRCT201205069650N1Phase 3Completed
- Sponsor
- Anesthesiology Research Center
- Start
- Jun 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium in coronary arteriosclerosis, sponsored by Anesthesiology Research Center. Primary endpoint: Change in proBNP levels. Started Jun 2012; status: completed.
02
Drugs
magnesium
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT201205069650N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201205069650N1.